Related Experiment Video
Updated: Jun 20, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis
S G Chu1, R C Becker, P B Berger
1University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Aim:
To determine whether an association exists between mean platelet volume (MPV) and acute myocardial infarction (AMI) and other cardiovascular events. Platelet activity is a major culprit in atherothrombotic events. MPV, which is widely available in clinical practice, is a potentially useful biomarker of platelet activity in the setting of cardiovascular disease.
Methods And Results:
We performed a systematic review and meta-analysis investigating the association between MPV and AMI, all-cause mortality following myocardial infarction, and restenosis following coronary angioplasty. Results were pooled using random-effects modeling. Pooled results from 16 cross-sectional studies involving 2809 patients investigating the association of MPV and AMI indicated that MPV was significantly higher in those with AMI than those without AMI [mean difference 0.92 fL, 95% confidence interval (CI) 0.67-1.16, P < 0.001). In subgroup analyses, significant differences in MPV existed between subjects with AMI, subjects with stable coronary disease (P < 0.001), and stable controls (P < 0.001), but not vs. those with unstable angina (P = 0.24). Pooled results from three cohort studies involving 3184 patients evaluating the risk of death following AMI demonstrated that an elevated MPV increased the odds of death as compared with a normal MPV (11.5% vs. 7.1%, odds ratio 1.65, 95% CI 1.12-2.52, P = 0.012). Pooled results from five cohort studies involving 430 patients who underwent coronary angioplasty revealed that MPV was significantly higher in patients who developed restenosis than in those who did not develop restenosis (mean difference 0.98 fL, 95% CI 0.74-1.21, P < 0.001).
Conclusions:
Elevated MPV is associated with AMI, mortality following myocardial infarction, and restenosis following coronary angioplasty. These data suggest that MPV is a potentially useful prognostic biomarker in patients with cardiovascular disease. Whether the relationship is causal, and whether MPV should influence practice or guide therapy, remains unknown.
Insights
Elevated mean platelet volume (MPV) is linked to acute myocardial infarction (AMI) and increased mortality risk after heart attack. Higher MPV also correlates with restenosis after angioplasty, suggesting its potential as a prognostic biomarker in cardiovascular disease.
Area of Science:
- Cardiology
- Hematology
- Biomarker Research
Background:
- Platelet activity plays a key role in atherothrombotic events.
- Mean platelet volume (MPV) is a readily available clinical measure reflecting platelet activation.
- MPV's association with cardiovascular disease warrants further investigation.
Purpose of the Study:
- To investigate the association between mean platelet volume (MPV) and acute myocardial infarction (AMI).
- To examine the relationship between MPV and cardiovascular outcomes, including mortality post-MI and restenosis after coronary angioplasty.
Main Methods:
- A systematic review and meta-analysis was conducted.
- Data from cross-sectional and cohort studies were pooled using random-effects modeling.
- Studies investigated MPV in relation to AMI, all-cause mortality after MI, and restenosis post-coronary angioplasty.
Main Results:
- MPV was significantly higher in patients with AMI compared to controls (mean difference 0.92 fL).
- Elevated MPV was associated with increased odds of death following myocardial infarction (OR 1.65).
- Higher MPV was observed in patients who developed restenosis after coronary angioplasty (mean difference 0.98 fL).
Conclusions:
- Elevated MPV is associated with acute myocardial infarction, post-MI mortality, and restenosis.
- MPV may serve as a prognostic biomarker in patients with cardiovascular disease.
- The causal nature of this association and its therapeutic implications require further study.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
